Skip to main content
. 2022 Nov 15;10:1072137. doi: 10.3389/fpubh.2022.1072137

Figure 9.

Figure 9

Subgroup analysis according to types of therapy. CAR-T, chimeric antigen receptor T-cell; BTKi, bruton tyrosine kinase inhibitor; Ven, venetoclax; HSCT, hematopoietic stem cell transplantation; Chem, chemotherapy; ICI, immune check-point inhibitors.